RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Chicago, IL · Evanston, IL · +84 more sites
2 recruiting crohn's disease studies with a site in Evanston, IL.
Sponsor: Merck Sharp & Dohme LLC
Chicago, IL · Evanston, IL · +84 more sites
Sponsor: Abivax S.A.
Evanston, IL · +42 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.